期刊文献+

eNOS基因转染治疗兔肺动脉高压及肺动脉高压危象 被引量:2

eNOS gene transfection on pulmonary artery hypertension and hypertension crisis in rabbits
原文传递
导出
摘要 目的探讨复制缺陷型重组腺病毒载体(AdCMVeNOS)介导内皮型一氧化氮合酶(eNOS)基因转染对左向右分流所致的肺动脉高压及肺动脉高压危象兔的影响。方法 18只肺动脉高压模型兔分成实验组(n=9)和对照组(n=9),实验组气管内滴入AdCMVeNOS病毒转染液(5×109PFU/mL)2mL,对照组滴入生理盐水2mL。4d后结扎左向右分流,同时气管插管吸入10%氧气,检测两组肺动脉收缩压(SPAP)、肺动脉平均压(MPAP)和平均动脉压(MAP)的变化;同时采用硝酸还原酶法测定肺组织一氧化氮(NO)浓度,检测外源性eNOS基因mRNA的表达。结果实验组肺动脉压较转染前明显下降(P<0.01),而对照组肺动脉压无明显改变,与实验组比较,差异有统计学意义(P<0.05)。缺氧60min后,实验组仅4只兔出现肺动脉高压危象,而对照组全部出现肺动脉高压危象。两组缺氧后均出现氧分压(PaO2)降低,二氧化碳分压(PaCO2)升高,SPAP、MPAP升高,MAP降低。恢复供氧后,实验组各测得值恢复至正常水平,对照组SPAP和MPAP高于基础值,MAP低于基础值(P<0.01),实验组SPAP、MPAP和PaCO2的升高幅度以及MAP和PaO2的降低幅度均低于对照组(P<0.01)。免疫组化染色显示实验组肺泡内皮细胞、肺中小血管的平滑肌细胞和内皮细胞的eNOS表达均较对照组明显增加,而且肺组织的NO浓度也明显高于对照组(P<0.001)。琼脂糖凝胶电泳显示,实验组在3.77kb处扩增出特异条带,而对照组在3.77kb处未扩增出特异条带。结论 AdCMVeNOS转染左向右分流所致的兔肺动脉高压动物模型,可有效降低肺动脉压和肺动脉高压危象的发生率。 Objective Effects of transfection of the endothelial nitric oxide synthase (eNOS) gene were studied in rabbits with pulmonary hypertension induced by left to right shunt or pulmonary hypertension crisis induced by hypoxia .Methods Eighteen pulmonary hypertension rabbits were divided into the experimental group (n=9) and the control group (n=9) .In the experimental group,an adenoviral vector encoding eNOS was intratracheally transfected .The same dosage of saline was intratracheally transfected in the control group.The left-right shunt was ligated 4 days after transfection,while 10% oxygen was inhaled through endotracheal intubation.Changes of pulmonary artery systolic pressure (SPAP) ,mean pulmonary artery pressure(MPAP) and mean arterial pressure(MAP) were detected.Concentration of NO and transgene expression mRNA were investigated.Results Compared with that before transfection,pulmonary artery pressure significantly decreased(P0.01) in the experimental group,while there was no change in the control group.There were significant differences between two groups after transfection.60min after hypoxia,all rabbits presented pulmonary hypertension crisis in the control group,but only 4 rabbits in the experimental group developed a crisis.Decreased PaO2 and MAP,increased PaCO2,SPAP and MPAP occurred in these two groups after hypoxia.But after the oxy-gen supply was restored,the variables recovered to normal levels in the experimental group.The variables of SPAP and MPAP were higher than their baseline,and MAP was lower in the control group.Comparing the variables (after vs before hypoxia) between the control group and the experimental group,the increasing extent of SPAP,MPAP and PaCO2 and de-creasing extent of MAP,CO and PaO2 in the experimental group were lower than those in the control group .With immuno-histochemical staining,expression of the eNOS gene in alveolar endothelial cells,smooth muscle cells and endothelial cells of small pulmonary vessels of the experimental group increased more than that of the control group.The concentration of NO in the experimental group was higher than that in the control group.Agarose gel electrophoresis showed an amplified 3.77 kb specific band in the experimental group,but not in the control group.Conclusions Intratracheal adenoviral-mediated eNOS gene transfection can reduce rabbits' pulmonary hypertension induced by left-to-right shunt and decrease occurrence rate of pulmonary hypertension crisis.
出处 《山东大学学报(医学版)》 CAS 北大核心 2010年第9期19-24,共6页 Journal of Shandong University:Health Sciences
基金 山东省自然科学基金资助项目(Y2005C30)
关键词 一氧化氮合酶基因 腺病毒载体 肺动脉高压 基因治疗 Nitric oxide synthase Adenovirus vector Pulmonary hypertension Gene therapy Rabbit
  • 相关文献

参考文献11

  • 1Chou T F,Wu M S, Chien C T, et al. Enhanced expression of nitric oxide synthase in the early stage after increased pulmonary blood flow in rats[J].Eur J Cardiothorac Surg, 2002, 21(2):331-336.
  • 2冯晓丽,朱晓波,陈欧,苏宏,马宇,王一彪.腺病毒介导eNOS转染高肺血流肺动脉高压大鼠模型的研究[J].山东大学学报(医学版),2010,48(1):70-73. 被引量:4
  • 3Feng Z, Shu W, Xian L, et al. Gene transfer of endothelial nitric oxide synthase attenuates flow-induced pulmonary hypertension in rabbits [J]. Ann Thorac Surg, 2008, 85(2) :581-585.
  • 4Nakamoto T, Harasawa H, Fuse D, et al. Nitric oxide and pulmonary hypertension [J]. Nippon Rinsho, 2004,62 ( Suppl 9 ) : 522-526.
  • 5Budts W, Pokreisz P, Nong Z, et al. Aerosol gene transfer with inducible nitric oxide synthase reduces hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats[J].Circulation, 2000, 102(23) :2880-2885.
  • 6Kang J L, Park W, Pack I S, et al. Inhaled nitric oxide attenuates acute lung injury via inhibition of nuclear factor-kappa B and inflammation[J].J Appl Physiol, 2002, 92(2) :795-801.
  • 7Champion H C, Bivalacqua T J, D' Souza F M, et al. Gene transfer of endothelial nitric oxide synthase to the lung of the mouse in vivo. Effect on agonist-induced and flow-mediated vascular responses [ J]. Circ Res, 1999, 84(12) : 1422-1432.
  • 8Janssens S P, Bloch K D, Nong Z, et al. Adenoviral-mediated transfer of the human endothelial nitric oxide synthase gene reduces acute hypoxic pulmonary vasoconstriction in rats[J]. J Clin Invest, 1996, 98(2) :317-324.
  • 9Rimar S, Gillis C N. Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation[J]. Circulation, 1993, 88(6): 2884-2887.
  • 10Han R N, Stewart D J. Defective lung vascular development in endthelial nitric oxide synthase deficient mice[J].Trends Cardiovas Med, 2006, 16( 1 ) :29-34.

二级参考文献9

  • 1赵翠芬,常萍,夏伟,杨杰,刘继玲,王玉玮,杨兴季.套管连接法建立大鼠左向右分流肺动脉高压模型[J].山东大学学报(医学版),2004,42(6):661-663. 被引量:13
  • 2Brown L, Miller J, Dagger A, et al. Cardiac and vascular responses 'after monocortatine-induced hypertrophy in rats [ J ]. Cardiovasc Pharmacol, 1998, 31(1): 108-115.
  • 3Garg U, Hassid A. Nitric oxide-generating vasodilators and 8- bromocychc guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cetls[J]. J Clin Invest, 1989, 83(5) : 1774-1777.
  • 4Moro M A, Russel R J, Celtek S, et al. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase[J]. Proc Natl Acad Sci, 1996, 93(4) : 1480-1485.
  • 5Nakamoto T, Harasawa H, Fuse D, et al. Nitric oxide and pulmonary hypertension [J]. Nippon Rinsho, 2004, 62 (Supp19) : 522-526.
  • 6Gautam A, Waldrep J C, Densmore C L. Aerosol gene therapy [J].Mol Bioteehnol, 2OO3, 23(1):51-60.
  • 7Everett A D, Le Cras T D, Xue C, et al. eNOS expression is not altered in pulmonary vascular remodeling due to increased pulmonary blood flow[J]. Am J Physiol, 1998, 274(6 Ptl): 1058-1065.
  • 8Komai H, Naito Y, Aimi Y, et al. Nitric oxide synthase expression in lungs of pulmonary hypertensive patients with heart disease[J]. Cardiovas Res, 2001, 10 (1):29-32.
  • 9Murata T, Sato K, Hori M, et al. Statin protects endothehal nitric oxide synthase activity in hypoxia-induced pulmonary hypertension[J].Arterioscler Thromb Vasc Biol, 2005, 25(11 ) : 2335-2342.

共引文献3

同被引文献26

  • 1曾嵘,庄建,岑坚正,陈欣欣,熊卫萍,朱卫中.枸橼酸西地那非治疗心脏手术后肺动脉高压的临床研究[J].中华心血管病杂志,2005,33(10):916-919. 被引量:28
  • 2张翼,杨黄恬,周兆年.间歇性低氧适应的心脏保护[J].生理学报,2007,59(5):601-613. 被引量:36
  • 3Friesen RH, Williams GD. Anesthetic management of children with pulmonary arterial hypertension [J]. Paediatr Anaesth, 2008, 18(3): 208-216.
  • 4Gali6 N, Corris PA, Forst A, et al. Updated treatment algorithm of pulmonary arterial hypertension [J]. J Am Coll Cardiol, 2013, 62(25 Suppl): D60-D72.
  • 5Brunner N, de Jesus Perez VA, Richter A, et aL Perioperative pharmacological management of pulmonary hypertensive crisis during congenital heart surgery [J]. Pulm Circ, 2014, 4(1): 10-24.
  • 6Bando K, Turrentine MW, Sharp TG, et al. Pulmonary hypertension after operations for congenital heart disease: analysis of risk factors and management [J]. J Thorac Cardiovasc Surg, 1996, 112(6): 1600-1607.
  • 7Antoniou T, Koletsis EN, Prokakis C, et al. Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery [J]. J Cardiothorac Vasc Anesth, 2013, 27(3): 459-466.
  • 8Adatia I, Beghetti M. Early postoperative care of patients with pulmonary hypertension associated with congenital cardiac disease [J]. Cardiol Young, 2009, 19(4): 315-319.
  • 9Germann P, Braschi A, Della Rocca G, et al. Inhaled nitric oxide therapy in adults: European expert recommendations [J]. Intensive Care Med, 2005, 31(8): 1029-1041.
  • 10Namachivayam P, Theilen U, Butt WW, et al. Sildenafil prevents rebound pulmonary hypertension after withdrawal of nitric oxide in children [J]. Am J Respir Crit Care Med, 2006, 174(9): 1042-1047.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部